Cargando…
Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
SIMPLE SUMMARY: Patients with unresectable hepatocellular carcinoma (HCC), the most common primary tumor of the liver, have poor prognosis and are increasing worldwide. The recent approval of several novel therapies for HCC was long expected, and it will make physician decision-making more challengi...
Autores principales: | Cucarull, Blanca, Tutusaus, Anna, Rider, Patricia, Hernáez-Alsina, Tania, Cuño, Carlos, García de Frutos, Pablo, Colell, Anna, Marí, Montserrat, Morales, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833604/ https://www.ncbi.nlm.nih.gov/pubmed/35158892 http://dx.doi.org/10.3390/cancers14030621 |
Ejemplares similares
-
Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species
por: Cucarull, Blanca, et al.
Publicado: (2021) -
Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models
por: Cucarull, Blanca, et al.
Publicado: (2020) -
Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma
por: Tutusaus, Anna, et al.
Publicado: (2018) -
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
por: Tutusaus, Anna, et al.
Publicado: (2019) -
Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice
por: Cuño-Gómiz, Carlos, et al.
Publicado: (2023)